ConductScience.org, home

Paper · 10694813

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19378998Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.J Immunol1997https://conductscience.org/library/papers/9378998PubMed
21540407The effect of cytokines and pharmacologic agents on chronic HIV infection.AIDS Res Hum Retroviruses1992https://conductscience.org/library/papers/1540407PubMed
37507183Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.J Virol1994https://conductscience.org/library/papers/7507183PubMed
43313729Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.Science1987https://conductscience.org/library/papers/3313729PubMed
58230463High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.J Virol1993https://conductscience.org/library/papers/8230463PubMed
69411749HIV survives drug onslaught by hiding out in T cells.Science1997https://conductscience.org/library/papers/9411749PubMed
78464405Pathogenesis of human immunodeficiency virus infection.Microbiol Rev1993https://conductscience.org/library/papers/8464405PubMed
89360927Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science1997https://conductscience.org/library/papers/9360927PubMed
98367455Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8367455PubMed
107983711An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy.J Virol1995https://conductscience.org/library/papers/7983711PubMed
119287227
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
N Engl J Med1997https://conductscience.org/library/papers/9287227PubMed
129360926Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science1997https://conductscience.org/library/papers/9360926PubMed
137584055Progress towards gene therapy for HIV infection.Gene Ther1994https://conductscience.org/library/papers/7584055PubMed
149653086Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.J Exp Med1998https://conductscience.org/library/papers/9653086PubMed
159287228Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.N Engl J Med1997https://conductscience.org/library/papers/9287228PubMed
167614253Antitat gene therapy: a candidate for late-stage AIDS patients.Gene Ther1995https://conductscience.org/library/papers/7614253PubMed
179060627Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.J Virol1997https://conductscience.org/library/papers/9060627PubMed
189144289Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature1997https://conductscience.org/library/papers/9144289PubMed
191676689Immunopathogenesis of HIV infection.FASEB J1991https://conductscience.org/library/papers/1676689PubMed
207913251Gene therapy for infectious diseases: the AIDS model.Trends Genet1994https://conductscience.org/library/papers/7913251PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/10694813/references